1h Free Analyst Time
The global acute respiratory distress syndrome treatment market is forecasted to grow by USD 1.43 billion during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of predisposing conditions and growing global geriatric population, continuous technological advancements in respiratory care and life support systems, rising healthcare expenditure and infrastructure development in emerging economies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global acute respiratory distress syndrome treatment market is segmented as below:
By Distribution Channel
- Hospitals pharmacies
- Retail pharmacies
- Online pharmacies
By Route Of Administration
- Oral
- Injection
- Inhalation
By Drug Class
- Corticosteroids and antibiotics
- Vasoconstrictors
- Bronchodilators
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
The report on the global acute respiratory distress syndrome treatment market covers the following areas:
- Global acute respiratory distress syndrome treatment market sizing
- Global acute respiratory distress syndrome treatment market forecast
- Global acute respiratory distress syndrome treatment market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Acute Respiratory Distress Syndrome Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Acute Respiratory Distress Syndrome Treatment Market 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 The impact of AI on global acute respiratory distress syndrome treatment market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospitals pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injection - Market size and forecast 2025-2030 ($ million)
- Data Table on Injection - Market size and forecast 2025-2030 ($ million)
- Chart on Injection - Year-over-year growth 2025-2030 (%)
- Data Table on Injection - Year-over-year growth 2025-2030 (%)
- Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
- Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
- Chart on Inhalation - Year-over-year growth 2025-2030 (%)
- Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Corticosteroids and antibiotics - Market size and forecast 2025-2030 ($ million)
- Data Table on Corticosteroids and antibiotics - Market size and forecast 2025-2030 ($ million)
- Chart on Corticosteroids and antibiotics - Year-over-year growth 2025-2030 (%)
- Data Table on Corticosteroids and antibiotics - Year-over-year growth 2025-2030 (%)
- Chart on Vasoconstrictors - Market size and forecast 2025-2030 ($ million)
- Data Table on Vasoconstrictors - Market size and forecast 2025-2030 ($ million)
- Chart on Vasoconstrictors - Year-over-year growth 2025-2030 (%)
- Data Table on Vasoconstrictors - Year-over-year growth 2025-2030 (%)
- Chart on Bronchodilators - Market size and forecast 2025-2030 ($ million)
- Data Table on Bronchodilators - Market size and forecast 2025-2030 ($ million)
- Chart on Bronchodilators - Year-over-year growth 2025-2030 (%)
- Data Table on Bronchodilators - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
- Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
- Chart on Taiwan - Year-over-year growth 2025-2030 (%)
- Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Increasing prevalence of predisposing conditions and growing global geriatric population
- Continuous technological advancements in respiratory care and life support systems
- Rising healthcare expenditure and infrastructure development in emerging economies
- Dual challenge of exorbitant treatment costs and absence of disease-modifying pharmacotherapies
- Clinical heterogeneity and diagnostic complexity of syndrome
- Intricate and high-risk clinical trial design and execution
- Impact of drivers and challenges in 2025 and 2030
- Focus on personalized medicine and ARDS phenotyping
- Growing emphasis on non-invasive and less invasive respiratory support
- Integration of artificial intelligence and digital health for predictive and optimized care
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Air Liquide SA - Overview
- Air Liquide SA - Business segments
- Air Liquide SA - Key news
- Air Liquide SA - Key offerings
- Air Liquide SA - Segment focus
- SWOT
- Dragerwerk AG and Co. KGaA - Overview
- Dragerwerk AG and Co. KGaA - Business segments
- Dragerwerk AG and Co. KGaA - Key offerings
- Dragerwerk AG and Co. KGaA - Segment focus
- SWOT
- Fisher and Paykel Healthcare - Overview
- Fisher and Paykel Healthcare - Product / Service
- Fisher and Paykel Healthcare - Key news
- Fisher and Paykel Healthcare - Key offerings
- SWOT
- Fresenius Medical Co. KGaA - Overview
- Fresenius Medical Co. KGaA - Business segments
- Fresenius Medical Co. KGaA - Key news
- Fresenius Medical Co. KGaA - Key offerings
- Fresenius Medical Co. KGaA - Segment focus
- SWOT
- GE HealthCare Technologies - Overview
- GE HealthCare Technologies - Business segments
- GE HealthCare Technologies - Key news
- GE HealthCare Technologies - Key offerings
- GE HealthCare Technologies - Segment focus
- SWOT
- Getinge AB - Overview
- Getinge AB - Business segments
- Getinge AB - Key news
- Getinge AB - Key offerings
- Getinge AB - Segment focus
- SWOT
- Hamilton Medical AG - Overview
- Hamilton Medical AG - Product / Service
- Hamilton Medical AG - Key offerings
- SWOT
- ICU Medical Inc. - Overview
- ICU Medical Inc. - Product / Service
- ICU Medical Inc. - Key offerings
- SWOT
- Koninklijke Philips N.V. - Overview
- Koninklijke Philips N.V. - Business segments
- Koninklijke Philips N.V. - Key news
- Koninklijke Philips N.V. - Key offerings
- Koninklijke Philips N.V. - Segment focus
- SWOT
- Loewenstein Medical - Overview
- Loewenstein Medical - Product / Service
- Loewenstein Medical - Key offerings
- SWOT
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- Nihon Kohden Corp. - Overview
- Nihon Kohden Corp. - Business segments
- Nihon Kohden Corp. - Key offerings
- Nihon Kohden Corp. - Segment focus
- SWOT
- Shenzhen Mindray Co. Ltd. - Overview
- Shenzhen Mindray Co. Ltd. - Business segments
- Shenzhen Mindray Co. Ltd. - Key offerings
- Shenzhen Mindray Co. Ltd. - Segment focus
- SWOT
- ZOLL Medical Corp. - Overview
- ZOLL Medical Corp. - Product / Service
- ZOLL Medical Corp. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Acute Respiratory Distress Syndrome Treatment Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospitals pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospitals pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospitals pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospitals pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
Exhibit 60: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Route of Administration ($ million)
Exhibit 73: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 74: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 75: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Drug Class
Exhibit 77: Data Table on Comparison by Drug Class
Exhibit 78: Chart on Corticosteroids and antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Corticosteroids and antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Corticosteroids and antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Corticosteroids and antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Vasoconstrictors - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Vasoconstrictors - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Vasoconstrictors - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Vasoconstrictors - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Bronchodilators - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Bronchodilators - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Bronchodilators - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Bronchodilators - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Drug Class ($ million)
Exhibit 95: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: Air Liquide SA - Overview
Exhibit 227: Air Liquide SA - Business segments
Exhibit 228: Air Liquide SA - Key news
Exhibit 229: Air Liquide SA - Key offerings
Exhibit 230: Air Liquide SA - Segment focus
Exhibit 231: SWOT
Exhibit 232: Dragerwerk AG and Co. KGaA - Overview
Exhibit 233: Dragerwerk AG and Co. KGaA - Business segments
Exhibit 234: Dragerwerk AG and Co. KGaA - Key offerings
Exhibit 235: Dragerwerk AG and Co. KGaA - Segment focus
Exhibit 236: SWOT
Exhibit 237: Fisher and Paykel Healthcare - Overview
Exhibit 238: Fisher and Paykel Healthcare - Product / Service
Exhibit 239: Fisher and Paykel Healthcare - Key news
Exhibit 240: Fisher and Paykel Healthcare - Key offerings
Exhibit 241: SWOT
Exhibit 242: Fresenius Medical Co. KGaA - Overview
Exhibit 243: Fresenius Medical Co. KGaA - Business segments
Exhibit 244: Fresenius Medical Co. KGaA - Key news
Exhibit 245: Fresenius Medical Co. KGaA - Key offerings
Exhibit 246: Fresenius Medical Co. KGaA - Segment focus
Exhibit 247: SWOT
Exhibit 248: GE HealthCare Technologies - Overview
Exhibit 249: GE HealthCare Technologies - Business segments
Exhibit 250: GE HealthCare Technologies - Key news
Exhibit 251: GE HealthCare Technologies - Key offerings
Exhibit 252: GE HealthCare Technologies - Segment focus
Exhibit 253: SWOT
Exhibit 254: Getinge AB - Overview
Exhibit 255: Getinge AB - Business segments
Exhibit 256: Getinge AB - Key news
Exhibit 257: Getinge AB - Key offerings
Exhibit 258: Getinge AB - Segment focus
Exhibit 259: SWOT
Exhibit 260: Hamilton Medical AG - Overview
Exhibit 261: Hamilton Medical AG - Product / Service
Exhibit 262: Hamilton Medical AG - Key offerings
Exhibit 263: SWOT
Exhibit 264: ICU Medical Inc. - Overview
Exhibit 265: ICU Medical Inc. - Product / Service
Exhibit 266: ICU Medical Inc. - Key offerings
Exhibit 267: SWOT
Exhibit 268: Koninklijke Philips N.V. - Overview
Exhibit 269: Koninklijke Philips N.V. - Business segments
Exhibit 270: Koninklijke Philips N.V. - Key news
Exhibit 271: Koninklijke Philips N.V. - Key offerings
Exhibit 272: Koninklijke Philips N.V. - Segment focus
Exhibit 273: SWOT
Exhibit 274: Loewenstein Medical - Overview
Exhibit 275: Loewenstein Medical - Product / Service
Exhibit 276: Loewenstein Medical - Key offerings
Exhibit 277: SWOT
Exhibit 278: Mallinckrodt Plc - Overview
Exhibit 279: Mallinckrodt Plc - Business segments
Exhibit 280: Mallinckrodt Plc - Key news
Exhibit 281: Mallinckrodt Plc - Key offerings
Exhibit 282: Mallinckrodt Plc - Segment focus
Exhibit 283: SWOT
Exhibit 284: Medtronic Plc - Overview
Exhibit 285: Medtronic Plc - Business segments
Exhibit 286: Medtronic Plc - Key news
Exhibit 287: Medtronic Plc - Key offerings
Exhibit 288: Medtronic Plc - Segment focus
Exhibit 289: SWOT
Exhibit 290: Nihon Kohden Corp. - Overview
Exhibit 291: Nihon Kohden Corp. - Business segments
Exhibit 292: Nihon Kohden Corp. - Key offerings
Exhibit 293: Nihon Kohden Corp. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Shenzhen Mindray Co. Ltd. - Overview
Exhibit 296: Shenzhen Mindray Co. Ltd. - Business segments
Exhibit 297: Shenzhen Mindray Co. Ltd. - Key offerings
Exhibit 298: Shenzhen Mindray Co. Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: ZOLL Medical Corp. - Overview
Exhibit 301: ZOLL Medical Corp. - Product / Service
Exhibit 302: ZOLL Medical Corp. - Key offerings
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Acute Respiratory Distress Syndrome Treatment Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospitals pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospitals pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospitals pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospitals pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
Exhibit 60: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Inhalation - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Inhalation - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Route of Administration ($ million)
Exhibit 73: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 74: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 75: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Drug Class
Exhibit 77: Data Table on Comparison by Drug Class
Exhibit 78: Chart on Corticosteroids and antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Corticosteroids and antibiotics - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Corticosteroids and antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Corticosteroids and antibiotics - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Vasoconstrictors - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Vasoconstrictors - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Vasoconstrictors - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Vasoconstrictors - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Bronchodilators - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Bronchodilators - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Bronchodilators - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Bronchodilators - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Drug Class ($ million)
Exhibit 95: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: Air Liquide SA - Overview
Exhibit 227: Air Liquide SA - Business segments
Exhibit 228: Air Liquide SA - Key news
Exhibit 229: Air Liquide SA - Key offerings
Exhibit 230: Air Liquide SA - Segment focus
Exhibit 231: SWOT
Exhibit 232: Dragerwerk AG and Co. KGaA - Overview
Exhibit 233: Dragerwerk AG and Co. KGaA - Business segments
Exhibit 234: Dragerwerk AG and Co. KGaA - Key offerings
Exhibit 235: Dragerwerk AG and Co. KGaA - Segment focus
Exhibit 236: SWOT
Exhibit 237: Fisher and Paykel Healthcare - Overview
Exhibit 238: Fisher and Paykel Healthcare - Product / Service
Exhibit 239: Fisher and Paykel Healthcare - Key news
Exhibit 240: Fisher and Paykel Healthcare - Key offerings
Exhibit 241: SWOT
Exhibit 242: Fresenius Medical Co. KGaA - Overview
Exhibit 243: Fresenius Medical Co. KGaA - Business segments
Exhibit 244: Fresenius Medical Co. KGaA - Key news
Exhibit 245: Fresenius Medical Co. KGaA - Key offerings
Exhibit 246: Fresenius Medical Co. KGaA - Segment focus
Exhibit 247: SWOT
Exhibit 248: GE HealthCare Technologies - Overview
Exhibit 249: GE HealthCare Technologies - Business segments
Exhibit 250: GE HealthCare Technologies - Key news
Exhibit 251: GE HealthCare Technologies - Key offerings
Exhibit 252: GE HealthCare Technologies - Segment focus
Exhibit 253: SWOT
Exhibit 254: Getinge AB - Overview
Exhibit 255: Getinge AB - Business segments
Exhibit 256: Getinge AB - Key news
Exhibit 257: Getinge AB - Key offerings
Exhibit 258: Getinge AB - Segment focus
Exhibit 259: SWOT
Exhibit 260: Hamilton Medical AG - Overview
Exhibit 261: Hamilton Medical AG - Product / Service
Exhibit 262: Hamilton Medical AG - Key offerings
Exhibit 263: SWOT
Exhibit 264: ICU Medical Inc. - Overview
Exhibit 265: ICU Medical Inc. - Product / Service
Exhibit 266: ICU Medical Inc. - Key offerings
Exhibit 267: SWOT
Exhibit 268: Koninklijke Philips N.V. - Overview
Exhibit 269: Koninklijke Philips N.V. - Business segments
Exhibit 270: Koninklijke Philips N.V. - Key news
Exhibit 271: Koninklijke Philips N.V. - Key offerings
Exhibit 272: Koninklijke Philips N.V. - Segment focus
Exhibit 273: SWOT
Exhibit 274: Loewenstein Medical - Overview
Exhibit 275: Loewenstein Medical - Product / Service
Exhibit 276: Loewenstein Medical - Key offerings
Exhibit 277: SWOT
Exhibit 278: Mallinckrodt Plc - Overview
Exhibit 279: Mallinckrodt Plc - Business segments
Exhibit 280: Mallinckrodt Plc - Key news
Exhibit 281: Mallinckrodt Plc - Key offerings
Exhibit 282: Mallinckrodt Plc - Segment focus
Exhibit 283: SWOT
Exhibit 284: Medtronic Plc - Overview
Exhibit 285: Medtronic Plc - Business segments
Exhibit 286: Medtronic Plc - Key news
Exhibit 287: Medtronic Plc - Key offerings
Exhibit 288: Medtronic Plc - Segment focus
Exhibit 289: SWOT
Exhibit 290: Nihon Kohden Corp. - Overview
Exhibit 291: Nihon Kohden Corp. - Business segments
Exhibit 292: Nihon Kohden Corp. - Key offerings
Exhibit 293: Nihon Kohden Corp. - Segment focus
Exhibit 294: SWOT
Exhibit 295: Shenzhen Mindray Co. Ltd. - Overview
Exhibit 296: Shenzhen Mindray Co. Ltd. - Business segments
Exhibit 297: Shenzhen Mindray Co. Ltd. - Key offerings
Exhibit 298: Shenzhen Mindray Co. Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: ZOLL Medical Corp. - Overview
Exhibit 301: ZOLL Medical Corp. - Product / Service
Exhibit 302: ZOLL Medical Corp. - Key offerings
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global acute respiratory distress syndrome treatment market: Air Liquide SA, Dragerwerk AG and Co. KGaA, Fisher and Paykel Healthcare, Fresenius Medical Co. KGaA, GE HealthCare Technologies, Getinge AB, Hamilton Medical AG, ICU Medical Inc., Koninklijke Philips N.V., LivaNova PLC, Loewenstein Medical, Mallinckrodt Plc, Medtronic Plc, Nihon Kohden Corp., Shenzhen Mindray Co. Ltd., Terumo Corp., ZOLL Medical Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is focus on personalized medicine and ards phenotyping."
According to the report, one of the major drivers for this market is the increasing prevalence of predisposing conditions and growing global geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Air Liquide SA
- Dragerwerk AG and Co. KGaA
- Fisher and Paykel Healthcare
- Fresenius Medical Co. KGaA
- GE HealthCare Technologies
- Getinge AB
- Hamilton Medical AG
- ICU Medical Inc.
- Koninklijke Philips N.V.
- LivaNova PLC
- Loewenstein Medical
- Mallinckrodt Plc
- Medtronic Plc
- Nihon Kohden Corp.
- Shenzhen Mindray Co. Ltd.
- Terumo Corp.
- ZOLL Medical Corp.
